The Globe and Mail reports in its Thursday, April 9, edition that Stifel analyst Justin Keywood has reaffirmed his "buy" recommendation for Savaria. The Globe's David Leeder writes that Mr. Keywood raised his share target to $29, matching the consensus. Mr. Keywood says in a note: "Savaria, a global assisted-lift leader (stair-lifts/home elevators/commercial lifts/low-rise elevators), benefitting from aging demographics and preference to 'age at home,' is expected to unveil new three to five year targets April 14. Savaria has a history of meeting ambitious goals. Most impressively was the two-year target to expand EBITDA margins from 15.5 per cent to 20 per cent (now 21 per cent). We believe Savaria One's next iteration and targets will be growth-focused ($1.1-billion-$1.3-billion sales, up 20 to 40 per cent) but with continued margin expansion from scale (100 to 200 basis points), suggesting value creation ahead. We are also encouraged by recent insider buying (March) at $25 to $26, near current prices. As Savaria sets and executes on new goals, valuation should rise toward mature elevator peers (11 times vs. 15 times) and with a higher market cap, S&P/TSX index inclusion is probably compounding success."